Therapeutic approaches beyond OGX-011, such as RNA interference strategies including microRNA (miRNA), short hairpin RNA (shRNA), and small interfering RNA (siRNA), have demonstrated efficacy in suppressing CLU expression across various cancers. This evidence concerns the gene CLU and cancer.